Interpace Biosciences Inc Market cap
What is the Market cap of Interpace Biosciences Inc?
The Market cap of Interpace Biosciences Inc is $4.48M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with market cap similar to Interpace Biosciences Inc
- Ragnar Metals has Market cap of $4.47M
- Sacheta Metals has Market cap of $4.47M
- Ignite has Market cap of $4.47M
- The Ravalgaon Sugar Farm has Market cap of $4.47M
- Emperor has Market cap of $4.48M
- Eros Resources has Market cap of $4.48M
- Interpace Biosciences Inc has Market cap of $4.48M
- Prakash Woollen & Synthetic Mills has Market cap of $4.48M
- Elys Game Technology has Market cap of $4.48M
- Yorkton Ventures has Market cap of $4.48M
- Chi Ho Development has Market cap of $4.48M
- Polychem has Market cap of $4.49M
- NuLegacy Gold has Market cap of $4.49M